ABT vs BMY: Options Risk Comparison

ABBOTT LABORATORIES and BRISTOL MYERS SQUIBB CO compared side by side — risk score, IV Rank, edge and earnings. Updated every 30 minutes.

Metric	ABT	BMY
Risk Score	39	44
Risk Band	LOW	LOW
IV Rank	71.9%	50.5%
IV %	35.5%	29.8%
Edge Score	+33	+6
Price Δ	+0.3%	+0.5%
Next Earnings	2026-07-16	2026-07-30
Sector	Health Care	Health Care

Which has higher options risk?

BRISTOL MYERS SQUIBB CO (BMY) currently carries the higher options risk score (44 vs 39 for ABT) — meaning more active catalysts that can drive an overnight move. For selling option premium, ABBOTT LABORATORIES (ABT) has the better edge score (+33) — a stronger blend of high IV Rank and low risk.

Risk score (0–100) reflects active catalysts — earnings, legal, SEC filings and news. Edge score = IV Rank − risk score; higher is better for selling premium.

Run a full scan on each — free

Scan ABT → Scan BMY →

ABT risk pages

ABT overview ABT IV / options ABT earnings BMY overview BMY IV / options BMY earnings

More Health Care comparisons

ABT vs ABBV ABT vs A ABT vs ALGN ABT vs AMGN ABT vs BAX ABT vs BDX ABT vs TECH ABT vs BIIB

TickerRisk provides risk scoring for informational purposes only. Not financial advice. Options trading involves substantial risk of loss. Full disclaimer